Screening for Early Diagnosis of Nose Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Screening for Early Diagnosis of Nose Cancer — Stella

Home/Nasopharyngeal Carcinoma/

View on ClinicalTrials.gov

Recruiting

Back to Nasopharyngeal Carcinoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Singapore

National University Hospital, Singapore

National University Polyclinics, Singapore

Key details

Sponsor

National University Hospital, Singapore

Collaborators

National Medical Research Council (NMRC), Singapore, Genome Institute of Singapore

Enrollment target

~20,000 participants

Started

November 2022

Primary completion

November 2027

Age range

35 Years – 60 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.